THYE DIRK (Chief Executive Officer) purchased 24.4% of their position (88K shares) of QUINCE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $110.9K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/11/2023ACC: 0001209191-23-045432
DirectorOfficer· Chief Executive Officer
Since May 2022
+88K
Net shares
Net buyer
$110.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
88K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+88K
Price / share
$1.26
Trade value
$110.88K
% of position
24.4%
8/10/2023
360.91K→448.91K
Total
Net shares
+88K
Net value
$110.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2023 | P · Purchase | +88K | $1.26 | $110.88K | 24.4% | 360.91K | 448.91K |
| Total | +88K | $110.88K | ||||||
Derivative Transactions0
No derivative transactions reported